This inventor holds 1 USPTO granted patent. Top assignee: Austria Wirtschaftsservice Gesellschaft MIT Beschrankter Haftung. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Johann Hofmann: Innovator in Anti-Cancer Agents
Introduction
Johann Hofmann is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer agents. His innovative work focuses on novel compounds that show promise in combating cancer, including multidrug-resistant forms.
Latest Patents
Hofmann holds a patent for "Heterocyclic hydrazones for use as anti-cancer agents." This invention relates to novel 2-benzimidazolyl-, 2-benzoxazolyl-, and 2-benzothiazolyl hydrazones derived from various chemical precursors. The patent outlines a novel method for producing these compounds and highlights their potential as effective therapeutic agents against cancer.
Career Highlights
Hofmann's career is marked by his dedication to research and innovation in the pharmaceutical field. His work has led to the development of compounds that are not only effective against cancer but also target multidrug-resistant cancer cells, showcasing his commitment to advancing cancer treatment.
Collaborations
Throughout his career, Hofmann has collaborated with esteemed colleagues such as Gottfried Heinisch and Johnny Easmon. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
Johann Hofmann's contributions to the field of anti-cancer agents exemplify the impact of innovative research in medicine. His patented work continues to pave the way for new therapeutic options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile